» Articles » PMID: 10326939

Processes and Outcomes of Care for Patients with Community-acquired Pneumonia: Results from the Pneumonia Patient Outcomes Research Team (PORT) Cohort Study

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 1999 May 18
PMID 10326939
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although understanding the processes of care and medical outcomes for patients with community-acquired pneumonia is instrumental to improving the quality and cost-effectiveness of care for this illness, limited information is available on how physicians manage patients with this illness or on medical outcomes other than short-term mortality.

Objectives: To describe the processes of care and to assess a broad range of medical outcomes for ambulatory and hospitalized patients with community-acquired pneumonia.

Methods: This prospective, observational study was conducted at 4 hospitals and 1 health maintenance organization in Pittsburgh, Pa, Boston, Mass, and Halifax, Nova Scotia. Data were collected via patient interviews and reviews of medical records for 944 outpatients and 1343 inpatients with clinical and radiographic evidence of community-acquired pneumonia. Processes of care and medical outcomes were assessed 30 days after presentation.

Results: Only 29.7% of outpatients had 1 or more microbiologic tests performed, and only 5.7% had an assigned microbiologic cause. Although 95.7% of inpatients had 1 or more microbiologic tests performed, a cause was established in only 29.6%. Six outpatients (0.6%) died, and 3 of these deaths were pneumonia related. Of surviving outpatients, 8.0% had 1 or more medical complications. At 30 days, 88.9% (nonemployed) to 95.6% (employed) of the surviving outpatients had returned to usual activities, yet 76.0% of outpatients had 1 or more persisting pneumonia-related symptoms. Overall, 107 inpatients (8.0%) died, and 81 of these deaths were pneumonia related. Most surviving inpatients (69.0%) had 1 or more medical complications. At 30 days, 57.3% (non-employed) to 82.0% (employed) of surviving inpatients had returned to usual activities, and 86.1% had 1 or more persisting pneumonia-related symptoms.

Conclusions: In this study, conducted primarily at hospital sites with affiliated medical education training programs, virtually all outpatients and most inpatients had pneumonia of unknown cause. Although outpatients had an excellent prognosis, pneumonia-related symptoms often persisted at 30 days. Inpatients had substantial mortality, morbidity, and pneumonia-related symptoms at 30 days.

Citing Articles

The use of machine learning based models to predict the severity of community acquired pneumonia in hospitalised patients: A systematic review.

Lythgoe C, Hamilton D, Johnston B, Ortega-Martorell S, Olier I, Welters I J Intensive Care Soc. 2025; :17511437251315319.

PMID: 39911517 PMC: 11791961. DOI: 10.1177/17511437251315319.


Pasteurella Multocida Infection in Humans.

Piorunek M, Brajer-Luftmann B, Walkowiak J Pathogens. 2023; 12(10).

PMID: 37887726 PMC: 10610061. DOI: 10.3390/pathogens12101210.


Acute Coronary Syndrome, Stroke, and Mortality after Community-Acquired Pneumonia: Systematic Review and Meta-Analysis.

Meregildo-Rodriguez E, Asmat-Rubio M, Rojas-Benites M, Vasquez-Tirado G J Clin Med. 2023; 12(7).

PMID: 37048661 PMC: 10095577. DOI: 10.3390/jcm12072577.


Acute organ injury and long-term sequelae of severe pneumococcal infections.

Kruckow K, Zhao K, Bowdish D, Orihuela C Pneumonia (Nathan). 2023; 15(1):5.

PMID: 36870980 PMC: 9985869. DOI: 10.1186/s41479-023-00110-y.


Cardiovascular Complications in Community-Acquired Pneumonia.

Desai A, Aliberti S, Amati F, Stainer A, Voza A Microorganisms. 2022; 10(11).

PMID: 36363769 PMC: 9695472. DOI: 10.3390/microorganisms10112177.